Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Clinicobacteriological evaluation of leprosy patients with 1-5 skin lesions.

Ansari A, Saxena K, Singh K, et al. International journal of mycobacteriology. 2020; 9 (2) : 209-211.
Download PDF
Publication

Health technologies for self-care promotion in patients with leprosy: exploring scientific evidence

Cavalcante JL, Xavier SPL, Cabral JFF, et al. Revista Baiana de Enfermagem. Revista Baiana de Enfermagem‏. 2020;
Download PDF
Publication

Squamous cell carcinoma on plantar perforating ulcer in an old leprosy: Case report

Achehboune K, Elloudi S, Issoual K, et al. International Journal of Dermatology Research. 2020; 2 (1) : 05-07.
Download PDF
Publication

A Clinical and Histopathological Correlation among Leprosy Patients (in this Post Elimination Era) Attending Tertiary Referral Centre

Thombare MM, Kote R, Gugle A, et al. Informatics Publishing Limited. MVP Journal of Medical Sciences. 2019; 6 (2) : 103-108.
Download PDF
Publication

Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic

World Health Organization . World Health Organization. 2020;
Download PDF
Publication

Persons Affected by Leprosy and the COVID-19 Global Health Crisis

Global Partnership for Zero Leprosy . 2020;
Download PDF
Publication

CHEMOPROPHYLAXIS VERSUS IMMUNOPROPHYLAXIS IN TUBERCULOSIS AND LEPROSY INFECTION

Novita BD. Jurnal Widya Medika. 2020; 6 (1) : 65-71.
Publication

Lepromatous Leprosy with Rosette

Laamari K, Baybay H, Jroundi C, et al. Austin J Dermatolog. 2020; 7 (1) : 1089.
Download PDF
Publication

Smear examination: An important tool in leprosy and relapse

Kalsy J, Kalra RK, Kaur D, et al. World Wide Journals. INDIAN JOURNAL OF APPLIED RESEARCH. 2018;
Download PDF
Publication

CARACTERIZAÇÃO DO ESTADO NUTRICIONAL DE PORTADORES DE HANSENÍASE REALIZANDO TRATAMENTO EM UM AMBULATÓRIO DE REFERÊNCIA

Gonçalves AGF, Torres RDS, Mattos DL, et al. Atena Editora. Dinâmica das Doenças Infecciosas 2. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 377
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD